2021. a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis. International Journal of Pharmacetical Sciences Letters. 11, 2 (Apr. 2021), 1–11.